This blog serves the purpose of providing information and happenings in the Pharma IP milieu.
Sunday, January 18, 2009
Cypress receives FDA approval of Levetiracetam oral solution
Cypress has been granted final approval by USFDA for it's ANDA for Levetiracetam Oral Solution, 100 mg/mL. Levetiracetam Oral Solution, 100 mg/mL is the AB-rated bioequivalent generic to UCB Pharma's Keppra® Oral Solution, 100 mg/mL.
No comments:
Post a Comment